Rapid-diagnostics company Cue Health earned $223.7 million in revenue for the third quarter of 2021, compared with $137.4 million for the prior quarter and $4.7 million for the prior year.
The company went public in late September, raising $213.9 million in proceeds after underwriting fees.
Net income dipped slightly to $19.3 million compared with $19.8 million in the second quarter, and earnings...
Cue Health, best known for its at-home COVID-19 molecular test, will launch its own virtual health platform, pushing the company outside of the diagnostics space.
The direct-to-consumer platform, available on Nov. 15, will include on-demand access to doctors, guided COVID-19 testing, prescriptions and physician-ordered lab tests. The virtual care offerings are part of a membership program, where...
Testing for COVID-19 has been somewhat of a roller coaster in the last few weeks. With each day, the FDA pushes forward in its efforts to expedite the review and rollout of sorely need COVID-19 diagnostic testing. It has enabled the Emergency Use Act, which relaxes standards during a time of crisis.
On March 30 the agency revealed that, since January, it has worked with more than 230 test...
Digital health startup Welltwigs has unveiled its fertility app, Fertility Monitor, along with two fertility-tracking devices at a TechCrunch event in New York this week.
The company's app tracks a woman's fertility cycle, but also monitors the woman's basal body temperature (BBT) with a product called Thermotwig and hormone levels with a device called Labtwig. Although other companies, including...
Humana's Cue app.
A new lab at Humana is dedicated to making sure HumanaVitality and other apps from the insurance giant have the same nimble development protocols as apps developed at a small startup would. A Wall Street Journal report this week offered a peek at the work being done at the Digital Experience Center that Humana launched last fall.
The new space houses 11 full-time employees...
San Diego, California-based Cue, not to be confused with fertility tracker company Clue, raised $7.5 million in a round led by SherpaVentures with participation from existing investor Immortalana.
SherpaVentures has previously invested in tech companies like Coin, DogVacay, and Uber, but this appears to be the firms first digital health investment.
Cue’s product, also called Cue, is a modular at-...
A few weeks ago, when we revisited Eric Topol's top 10 digital health predictions, Topol mentioned microfluidics -- and the ability to create home versions of medical lab tests -- as one of the unexpected breakthroughs of the last five years.
"All the routine labs could be run through the smartphone with a very simple microfluidic adapter — any lab test could," he said at the time. "Then there’s...
